Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

STO/ORX stock hub

STO/ORX has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

STO/ORXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

645.4M

Nasdaq Stockholm

Market data

Live price

Current market quote for this ticker.

Current price

STO/ORX

In the news

Latest news · STO/ORX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E1.2

P25 n/aP50 n/aP75 n/a

ROE-410.9

P25 n/aP50 n/aP75 n/a

ROIC-1,253.6

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All STO/ORX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

192

Groups with data

Currency

SEK

Showing 192 of 192 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Sweden
Country code	SE
Employees	74
Employees Change	-36%
Employees Change Percent	-32.73
Enterprise value	SEK 266.2M
Exchange	Nasdaq Stockholm
Financial currency	SEK
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	SE0000736415
Last refreshed	2026-05-10
Market cap	SEK 645.4M
Price	SEK 18.48
Price currency	SEK
Rev Per Employee	273,846.15x
Sector	Healthcare
Sic	2834
Symbol	sto/ORX
Website	https://www.orexo.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	80.78%
EV Earnings	0.51x
EV/FCF	0.35x
EV/Sales	14.95x
FCF yield	117.05%
P/B ratio	1.77x
P/E ratio	1.24x
P/S ratio	36.26x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
FCF margin	4,243.82%
Gross margin	42.13%
Gross Profit	SEK 7.5M
Gross Profit Growth Q	-47.06%
Gross Profit Growth3 Y	-75.66%
Gross Profit Growth5 Y	-57.73%
Net Income	SEK 521.3M
Net Income Growth Years	1%
Pretax Margin	-2,342.13%
Profit Margin	2,928.65%
Profit Per Employee	SEK 8M
ROA	-37.96
Roa5y	-16.53
ROCE	-92.22
ROE	-410.9
ROIC	-1,253.6
Roic5y	-95.73

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-8.72%
Cagr15y	-4.95%
Cagr1y	23.22%
Cagr20y	-10.1%
Cagr3y	19.6%
Cagr5y	-15.01%
EPS Growth Years	1
FCF Growth	4,591.93%
OCF Growth	4,097.22%
Revenue Growth	-12.46x
Revenue Growth Q	-62.12x
Revenue Growth Years	0x
Revenue Growth3 Y	-69.44x
Revenue Growth5 Y	-50.85x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	SEK 0.03
Assets	SEK 610.4M
Cash	SEK 386.2M
Current Assets	SEK 476.3M
Current Liabilities	SEK 235.2M
Debt	SEK 7M
Debt Equity	SEK 0.02
Debt FCF	SEK 0.01
Equity	SEK 364.7M
Interest Coverage	-5.15
Liabilities	SEK 245.7M
Long Term Assets	SEK 134.1M
Long Term Liabilities	SEK 10.5M
Net Cash	SEK 379.2M
Net Cash By Market Cap	SEK 58.76
Net Debt Equity	SEK -1.04
Net Debt FCF	SEK -0.5
Tangible Book Value	SEK 364.3M
Tangible Book Value Per Share	SEK 10.37
WACC	17.09

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.03
Net Working Capital	SEK -140.9M
Quick ratio	1.97
Working Capital	SEK 241.1M
Working Capital Turnover	SEK 0.09

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.8%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-59.83%
1Y total return	23.2%
200-day SMA	26.17
3Y total return	71.11%
50-day SMA	22.09
50-day SMA vs 200-day SMA	50under200
5Y total return	-55.66%
All Time High	183.5
All Time High Change	-89.93%
All Time High Date	2013-12-03
All Time Low	8.44
All Time Low Change	118.96%
All Time Low Date	2023-06-13
ATR	1.14
Beta	0.87
Beta1y	0.97
Beta2y	0.74
Ch YTD	-38.6
High	18.94
High52	43.4
High52 Date	2025-10-10
High52ch	-57.42%
Low	18.06
Low52	13.56
Low52 Date	2025-05-20
Low52ch	36.28%
Ma50ch	-16.32%
Price vs 200-day SMA	-29.39%
RSI	36.44
RSI Monthly	45.76
RSI Weekly	35.01
Sharpe ratio	0.64x
Sortino ratio	1.1
Total Return	-0.8%
Tr YTD	-38.6
Tr15y	-53.31%
Tr1m	-8.97%
Tr1w	-0.65%
Tr3m	-34.7%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	SEK -346M
Operating margin	-1,943.8

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	21,325,631%
Net Borrowing	-490,700,000
Shares Insiders	10.48%
Shares Institutions	19.23%
Shares Out	34,921,643
Shares Qo Q	1.21%
Shares Yo Y	0.8%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	SEK 753M
Average Volume	47,848.3x
Bv Per Share	10.38
CAPEX	SEK -100,000
Ch10y	-59.83
Ch15y	-53.33
Ch1m	-8.97
Ch1w	-0.65
Ch1y	23.2
Ch20y	-88.12
Ch3m	-34.7
Ch3y	71.11
Ch5y	-55.66
Ch6m	-32.68
Change	2.1%
Change From Open	1.43
Close	18.1
Days Gap	0.66
Depreciation Amortization	42,700,000
Dollar Volume	195,647.8
Earnings Date	2026-04-28
EBIT	SEK -346M
EBITDA	SEK -303.3M
EPS	SEK 14.98
F Score	4
FCF	SEK 755.4M
FCF EV Yield	283.82x
FCF Per Share	SEK 21.63
Financing CF	-490,700,000
Fiscal Year End	December
Founded	1,994
Graham Number	59.22545
Graham Upside	220.5
Income Tax	SEK 1M
Investing CF	-200,000
Is Primary Listing	1
Last Earnings Date	2026-04-28
Last Report Date	2026-03-31
Ma150	27.29
Ma150ch	-32.28%
Ma20	19.76
Ma20ch	-6.49%
Net CF	267,100,000
Next Earnings Date	2026-07-16
Open	18.22
P FCF Ratio	0.85
P OCF Ratio	0.85
Position In Range	47.73
Ppne	50,300,000
Price Date	2026-05-08
Ptbv Ratio	1.77
Relative Volume	0.21x
Revenue	17,800,000x
SBC By Revenue	13.48x
Share Based Comp	2,400,000
Tax By Revenue	5.62x
Tr20y	-88.11%
Tr6m	-32.68%
Volume	10,587

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does STO/ORX pay a dividend?

Capital-return profile for this ticker.

Performance

STO/ORX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns STO/ORX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+19.2%

Share of float held by funds and institutions

Insider ownership

+10.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.8%

Negative means the company is buying back shares.

Technical

STO/ORX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

36.4

Neutral momentum band

Price vs 200-day MA

-29.4%

50/200-day relationship not available

Beta (5Y)

0.87

Moves roughly with the market

Sharpe ratio

0.64

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About STO/ORX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sto/ORX stock rating?

sto/ORX is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sto/ORX analysis?

The full report lives at /stocks/sto/ORX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sto/ORX?

The latest report frames sto/ORX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sto/ORX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.